TAMPA, Fla. & LOS ANGELES–(BUSINESS WIRE)–Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: FLGT) and a leading nanobiotechnology company specializing in innovative cancer therapeutics, announced today a strategic partnership aimed at advancing cancer treatment through clinical development and…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
